Literature DB >> 18056002

Missense mutation of the last nucleotide of exon 1 (G->C) of beta globin gene not only leads to undetectable mutant peptide and transcript but also interferes with the expression of wild allele.

Neeraj Agarwal1, Ferdane Kutlar, Mariluz P Mojica-Henshaw, Ching N Ou, Amos Gaikwad, N Scott Reading, Lakeia Bailey, Abdullah Kutlar, Josef T Prchal.   

Abstract

Hemoglobin Monroe (beta globin G->C, codon 30) is a missense mutation. We could not detect either the mutant peptide or transcript in reticulocyte-enriched preparation and in expanded erythroid progenitor cells. By quantitative gene expression assay beta globin mRNA was found to be reduced by more than 70% in all heterozygous subjects with different haplotypes. We conclude that this mutation also interferes with expression of wild type allele.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056002     DOI: 10.3324/haematol.11543

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  Terminal osseous dysplasia is caused by a single recurrent mutation in the FLNA gene.

Authors:  Yu Sun; Rowida Almomani; Emmelien Aten; Jacopo Celli; Jaap van der Heijden; Hanka Venselaar; Stephen P Robertson; Anna Baroncini; Brunella Franco; Lina Basel-Vanagaite; Emiko Horii; Ricardo Drut; Yavuz Ariyurek; Johan T den Dunnen; Martijn H Breuning
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

2.  The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer.

Authors:  Ciyu Yang; Angela G Arnold; Amanda Catchings; Vikas Rai; Zsofia K Stadler; Liying Zhang
Journal:  Breast Cancer Res Treat       Date:  2021-01-16       Impact factor: 4.872

3.  The conserved Phe GH5 of importance for hemoglobin intersubunit contact is mutated in gadoid fish.

Authors:  Øivind Andersen; Maria Cristina De Rosa; Prakash Yadav; Davide Pirolli; Jorge M O Fernandes; Paul R Berg; Sissel Jentoft; Carl Andrè
Journal:  BMC Evol Biol       Date:  2014-03-21       Impact factor: 3.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.